Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Neospora caninum: In vivo and in vitro treatment with artemisone
Monica L. Mazuz
, Richard Haynes
, Varda Shkap
, Leah Fish
, Ricardo Wollkomirsky
, Benjamin Leibovich
, Thea Molad
, Igor Savitsky
,
Jacob Golenser
*
*
Corresponding author for this work
Institute for Medical Research Israel-Canada (IMRIC)
Research output
:
Contribution to journal
›
Article
›
peer-review
31
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Neospora caninum: In vivo and in vitro treatment with artemisone'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antibody Titer
16%
Antimalarial Activity
16%
Artemisinin
100%
Artemisinin Derivatives
16%
Cattle Industry
16%
Clinical Impact
16%
Clinical Symptoms
16%
Epidemiological Impact
16%
Gerbil
16%
Gerbil Model
16%
Global Economic Impact
16%
In Vivo Applications
100%
In Vivo Pharmacokinetics
16%
Infected Cells
16%
Infection Treatment
16%
Metabolic Stability
16%
Micromolar Concentration
16%
Neospora
33%
Neospora Caninum
100%
Neosporosis
50%
Number of Infected
16%
Pharmacokinetic Stability
16%
Post-infection
16%
Semi-synthetic
16%
Significant Benefit
16%
Specific Antibodies
16%
Toxic Dose
16%
Biochemistry, Genetics and Molecular Biology
Antimalarial Activity
50%
Gerbil
50%
Gerbil Model
50%
Neospora
100%
Neospora Caninum
100%
Pharmacokinetics
50%
Titer
50%
Toxic Dose
50%
Pharmacology, Toxicology and Pharmaceutical Science
Antimalarial Activity
20%
Artemisinin
20%
Artemisinin Derivative
20%
Artemisone
100%
Gerbil
20%
Gerbil Model
20%
Infection
20%
Neospora
20%
Neospora Caninum
100%
Neosporosis
80%
Pharmacokinetics
20%